Target Price | $22.44 |
Price | $9.28 |
Potential |
141.81%
register free of charge
|
Number of Estimates | 10 |
10 Analysts have issued a price target Immunome Inc 2026 .
The average Immunome Inc target price is $22.44.
This is
141.81%
register free of charge
$39.90
329.96%
register free of charge
$20.20
117.67%
register free of charge
|
|
A rating was issued by 15 analysts: 14 Analysts recommend Immunome Inc to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Immunome Inc stock has an average upside potential 2026 of
141.81%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 9.04 | 7.07 |
35.52% | 21.85% | |
EBITDA Margin | -1,674.23% | -2,815.29% |
738.31% | 68.15% | |
Net Margin | -3,240.71% | -2,784.14% |
325.38% | 14.09% |
10 Analysts have issued a sales forecast Immunome Inc 2025 . The average Immunome Inc sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Immunome Inc EBITDA forecast 2025. The average Immunome Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
11 Immunome Inc Analysts have issued a net profit forecast 2025. The average Immunome Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -5.00 | -2.26 |
7.06% | 54.80% | |
P/E | negative | |
EV/Sales | 76.40 |
11 Analysts have issued a Immunome Inc forecast for earnings per share. The average Immunome Inc EPS is
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
Guggenheim |
Locked
➜
Locked
|
Locked | Aug 25 2025 |
Evercore ISI Group |
Locked
➜
Locked
|
Locked | Aug 22 2025 |
JP Morgan |
Locked
➜
Locked
|
Locked | Aug 07 2025 |
Lake Street |
Locked
➜
Locked
|
Locked | Apr 02 2025 |
Guggenheim |
Locked
➜
Locked
|
Locked | Mar 20 2025 |
Stephens & Co. |
Locked
➜
Locked
|
Locked | Mar 20 2025 |
Wedbush |
Locked
➜
Locked
|
Locked | Mar 20 2025 |
Analyst Rating | Date |
---|---|
Locked
Guggenheim:
Locked
➜
Locked
|
Aug 25 2025 |
Locked
Evercore ISI Group:
Locked
➜
Locked
|
Aug 22 2025 |
Locked
JP Morgan:
Locked
➜
Locked
|
Aug 07 2025 |
Locked
Lake Street:
Locked
➜
Locked
|
Apr 02 2025 |
Locked
Guggenheim:
Locked
➜
Locked
|
Mar 20 2025 |
Locked
Stephens & Co.:
Locked
➜
Locked
|
Mar 20 2025 |
Locked
Wedbush:
Locked
➜
Locked
|
Mar 20 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.